Robert H. Resis provides useful strategies for petitioners in inter partes review proceedings in biotechnology and pharmaceutical patents in Part II of his two-part series in BNA’s Patent, Trademark and Copryight Journal.
Please click here to read, “A Petitioner’s Guide to Handling IPRs in the Higher-Survival Patent Arena of Biotech and Pharmaceuticals.” A subscription is required.
Please click here for a PDF version.
Posted: April 15, 2016